Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051298
Status:
COMPLETED
Last Update Posted:
2007-06-12
First Post:
2003-01-07
Brief Title:
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-04
Completion Date Type:
ACTUAL
First Submit Date:
2003-01-07
First Submit QC Date:
January 8 2003
Study First Post Date:
2003-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-06-11
Last Update Post Date:
2007-06-12
Last Update Post Date Type:
ESTIMATED